INSM has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
INSM has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Insmed's General and Admin. Expense for the three months ended in Sep. 2024 was $118.9 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Sep. 2024 was $408.1 Mil.
The historical data trend for Insmed's General and Admin. Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Insmed Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
General and Admin. Expense | Get a 7-Day Free Trial | 210.80 | 203.61 | 234.27 | 265.78 | 344.50 |
Insmed Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
General and Admin. Expense | Get a 7-Day Free Trial | 90.63 | 89.53 | 93.10 | 106.57 | 118.93 |
General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.
General and Admin. Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $408.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Insmed's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.
Flammer Martina M.d. | officer: Chief Medical Officer | 700 US HIGHWAY 202/206, BRIDGEWATER NJ 08807 |
Michael Alexander Smith | officer: General Counsel, Senior VP | 700 US HIGHWAY 202/206, BRIDGEWATER NJ 08807 |
Schaeffer Orlov S Nicole | officer: Chief People Strategy Officer | INSMED INCORPORATED, 10 FINDERNE AVENUE, BRIDGEWATER NJ 08807 |
Sara Bonstein | officer: Chief Financial Officer | 305 COLLEGE ROAD EAST, PRINCETON NJ 08540 |
John Drayton Wise | officer: Chief Commercial Officer | 700 US HIGHWAY 202/206, BRIDGEWATER NJ 08807 |
Roger Adsett | officer: Chief Commercial Officer | 10 FINDERNE AVENUE, BRIDGEWATER NJ 08807 |
William Lewis | officer: President & CEO | 10 FINDERNE AVENUE, BUILDING 10, BRIDGEWATER NJ 08807 |
Melvin Md Sharoky | director | 10 FINDERNE AVENUE, BUILDING 10, BRIDGEWATER NJ 08807 |
Leo Lee | director | 10 FINDERNE AVENUE, BRIDGEWATER NJ 08807 |
David R Brennan | director | C/O INSMED INCORPORATED, 10 FINDERNE AVENUE, BRIDGEWATER NJ 08807 |
Steinar J Engelsen | director | 10 FINDERNE AVENUE, BUILDING 10, BRIDGEWATER NJ 08807 |
John Soriano | officer: Chief Compliance Officer | 10 FINDERNE AVENUE, BRIDGEWATER NJ 08807 |
Christine A Pellizzari | officer: General Counsel & Secretary | 10 FINDERNE AVENUE, BRIDGEWATER NJ 08807 |
Alfred Altomari | director | C/O AGILE THERAPEUTICS, INC., 101 POOR FARM ROAD, PRINCETON NJ 08540 |
Elizabeth M Anderson | director | 10 FINDERNE AVENUE, BUILDING 10, BRIDGEWATER NJ 08807 |
From GuruFocus
By PRNewswire • 08-02-2024
By PRNewswire • 10-23-2024
By PRNewswire • 07-05-2024
By PRNewswire • 06-27-2024
By PRNewswire • 09-06-2024
By PRNewswire • 05-30-2024
By PRNewswire • 10-24-2024
By PRNewswire • 05-30-2024
By PRNewswire • 06-05-2024
By GuruFocus News • 11-01-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.